Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
ConditionArthritis, Rheumatoid
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Michigan
About this trial
The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.
Eligibility criteria
Qualifiers
Men and women 18 years of age or older can participate in this study.
Patients can participate in this study if they have had rheumatoid arthritis for more than 2 years and their rheumatologist has referred them to this study.
Patients can participate as a healthy volunteer with a known history of rheumatoid arthritis.
Disqualifiers
Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
Pregnant patients.
Patients who is claustrophobic.
Patients with impaired renal function cannot participate in this study such as elevate creatinine clearance, patients on kidney dialysis etc.
Trial design
Treatments tested in this trial
- Laser Based Photoacoustic Tomography, MRI, Ultrasound
- laser based photoacoustic tomography, MRI, ultrasound
Treatment groups
113 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Michigan
Lead sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
Source ClinicalTrials.gov